Breakdown | TTM | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 |
---|---|---|---|---|---|---|
Income Statement | ||||||
Total Revenue | 654.72M | 703.63M | 836.52M | 782.36M | 626.72M | 395.52M |
Gross Profit | 266.85M | 286.32M | 304.71M | 253.31M | 198.97M | 98.81M |
EBITDA | 68.46M | 98.87M | 170.51M | 167.08M | 117.00M | 67.20M |
Net Income | 10.75M | 34.66M | 107.47M | 109.46M | 91.31M | 40.34M |
Balance Sheet | ||||||
Total Assets | 1.38B | 1.41B | 1.39B | 1.16B | 1.04B | 366.57M |
Cash, Cash Equivalents and Short-Term Investments | 20.11M | 25.27M | 18.39M | 47.89M | 21.57M | 21.66M |
Total Debt | 309.86M | 339.64M | 301.86M | 241.96M | 240.40M | 42.93M |
Total Liabilities | 551.51M | 573.24M | 543.28M | 412.57M | 397.20M | 104.05M |
Stockholders Equity | 828.35M | 834.17M | 850.49M | 745.64M | 644.26M | 262.53M |
Cash Flow | ||||||
Free Cash Flow | 58.26M | 31.10M | 28.52M | 43.61M | 40.87M | 33.55M |
Operating Cash Flow | 122.34M | 102.28M | 83.78M | 88.94M | 88.26M | 53.26M |
Investing Cash Flow | -64.22M | -71.56M | -159.24M | -47.81M | -182.62M | -19.65M |
Financing Cash Flow | -57.78M | -23.80M | 45.92M | -14.76M | 94.29M | -15.26M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
71 Outperform | $55.96B | 15.51 | 35.83% | 3.12% | -1.21% | -8.89% | |
67 Neutral | $13.24B | 15.39 | 23.14% | 3.20% | -4.90% | -14.49% | |
66 Neutral | $13.24B | 15.16 | 23.14% | 3.37% | -4.90% | -14.49% | |
65 Neutral | $27.28B | 15.30 | -4.01% | 3.16% | 1.00% | 1.98% | |
64 Neutral | $680.27M | 70.10 | 1.28% | 1.60% | -18.78% | -89.51% | |
61 Neutral | $28.54B | 49.10 | -5.05% | 2.45% | -0.47% | -117.62% | |
52 Neutral | $12.23M | ― | -23.93% | ― | -24.81% | 80.45% |
On May 20, 2025, MGP Ingredients held its Annual Meeting of Stockholders, where directors were elected, KPMG LLP’s appointment as the independent accounting firm was ratified, and executive compensation was approved. On May 27, 2025, MGP announced leadership changes with Martin Roper elected as Chairman of the Board. Roper, who joined the board in April 2025, brings extensive industry experience and aims to enhance MGP’s strategic priorities and shareholder value. The board also appointed new chairs for its Audit, Nominating and Governance, and Human Resources and Compensation Committees, signaling a strategic shift as MGP evolves into a premier branded spirits organization.
The most recent analyst rating on (MGPI) stock is a Buy with a $80.00 price target. To see the full list of analyst forecasts on MGP Ingredients stock, see the MGPI Stock Forecast page.
On April 14, 2025, MGP Ingredients announced the election of Gerardo I. Lopez and Martin Roper as independent directors to its Board, with terms expiring at the company’s 2025 annual meeting of stockholders. Both directors bring significant industry expertise and have been appointed to key committees, while receiving equity grants valued at $90,000. Concurrently, Preet H. Michelson resigned from the Board, with the company expressing gratitude for her contributions. These changes aim to strengthen MGP’s strategic direction and operational excellence, with the Board now comprising nine directors, eight of whom are independent.